KY Biotechnology & Medical Research

Connect Biopharma Holdings Ltd (CNTB)

Track

Connect Biopharma Holdings Ltd has seen recent insider activity characterized by a single purchase of $371,610 by James Huang on May 29, 2026. This follows a larger purchase by the same individual earlier in the year. The stock has experienced a 15.7% decline over the past 90 days, with the next results financiers scheduled for August 2026.
Ticker: CNTB Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Buy 29 May 2026
Value US$216,037.91 | Price 389.07 | Shares 76,040 (-38.7%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-02 2026-05-29 B Purchase
2.4
Huang James
Non-Executive Director
76,040 -38.7%
389.07
US$216,038 		76,040 -38.7% 389.07 US$216,038
2026-04-01 2026-03-31 B Purchase
2.4
Huang James
Non-Executive Director
93,359 +38.2%
86.70
US$4,553,451 		93,359 +38.2% 86.70 US$4,553,451
2025-11-24 2025-11-24 PrS Proposed sale
2.1
Panacea Innovation Limited

10% Owner

Large shareholder
78,275
448.92
US$1,820,248 		78,275 448.92 US$1,820,248
2025-11-21 2025-11-21 PrS Proposed sale
Wei Zheng

10% Stockholder

Large shareholder
650,000
3.19
US$2,073,500 		650,000 3.19 US$2,073,500
2025-11-18 2025-11-18 PrS Proposed sale
BioFortune Inc

10% Stockholder

Large shareholder
500,000
2.49
US$1,245,000 		500,000 2.49 US$1,245,000
2025-10-01 2025-10-01 PrS Proposed sale
Wei Zheng

10% Stockholder

Large shareholder
200,000
1.53
US$305,940 		200,000 1.53 US$305,940
2025-06-11 2025-06-11 PrS Proposed sale
Wei Zheng

10% Stockholder

Large shareholder
39,775
0.81
US$32,218 		39,775 0.81 US$32,218
2023-12-18 2023-12-18 PrS Proposed sale
RA Capital Nexus Fund, L.P.

10% Stockholder

Large shareholder
295,650
0.94
US$279,034 		295,650 0.94 US$279,034
2023-12-18 2023-12-18 PrS Proposed sale
RA Capital Healthcare Fund LP

10% Stockholder

Large shareholder
1,765,788
0.94
US$1,666,551 		1,765,788 0.94 US$1,666,551
2023-12-12 2023-12-12 PrS Proposed sale
RA Capital Nexus Fund, L.P.

10% Stockholder

Large shareholder
36,959
0.90
US$33,263 		36,959 0.90 US$33,263
2023-12-12 2023-12-12 PrS Proposed sale
RA Capital Healthcare Fund LP

10% Stockholder

Large shareholder
220,738
0.90
US$198,664 		220,738 0.90 US$198,664
2023-11-27 2023-11-27 PrS Proposed sale
RA Capital Nexus Fund, L.P.

10% Stockholder

Large shareholder
151,778
1.29
US$195,793 		151,778 1.29 US$195,793
2023-11-27 2023-11-27 PrS Proposed sale
RA Capital Healthcare Fund LP

10% Stockholder

Large shareholder
906,504
1.29
US$1,169,390 		906,504 1.29 US$1,169,390
2023-11-21 2023-11-21 PrS Proposed sale
RA Capital Nexus Fund, L.P.

10% Stockholder

Large shareholder
78,983
2.06
US$162,704 		78,983 2.06 US$162,704
2023-11-21 2023-11-21 PrS Proposed sale
RA Capital Healthcare Fund LP

10% Stockholder

Large shareholder
471,732
2.06
US$971,767 		471,732 2.06 US$971,767
Explore more

More insider trading research around Connect Biopharma Holdings Ltd

More insider trades in KY
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity